VSee Health Inc. (VSEE)
NASDAQ: VSEE
· Real-Time Price · USD
0.69
-0.01 (-0.73%)
At close: Sep 16, 2025, 2:05 PM
-0.73% (1D)
| Bid | 0.67 |
| Market Cap | 11.22M |
| Revenue (ttm) | 10.42M |
| Net Income (ttm) | -58.67M |
| EPS (ttm) | -5.63 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | n/a |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.7 |
| Volume | 16,339 |
| Avg. Volume (20D) | 768,303 |
| Open | 0.68 |
| Previous Close | 0.70 |
| Day's Range | 0.67 - 0.71 |
| 52-Week Range | 0.58 - 3.54 |
| Beta | 0.35 |
| Ex-Dividend Date | n/a |
About VSEE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VSEE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VSEE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+13.11%
VSee Health shares are trading higher after the co...
Unlock content with
Pro Subscription
2 months ago
+2.75%
VSee Health shares are trading higher after the company announced it was selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation.
2 months ago · businesswire.com
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical TrialSAN JOSE, Calif.--(BUSINESS WIRE)-- #clinicaltrial--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 cl...